KORU Medical Systems, Inc.
KRMD
$4.33
$0.071.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.57% | 19.65% | 17.99% | 11.57% | 4.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.57% | 19.65% | 17.99% | 11.57% | 4.70% |
| Cost of Revenue | 17.44% | 9.87% | 4.28% | -2.68% | -11.06% |
| Gross Profit | 20.85% | 26.10% | 27.67% | 22.15% | 17.16% |
| SG&A Expenses | 9.77% | 9.54% | 6.22% | 3.50% | 0.00% |
| Depreciation & Amortization | -3.07% | -1.58% | 2.10% | 9.12% | 14.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.85% | 6.02% | 3.36% | -0.54% | -4.52% |
| Operating Income | 32.08% | 37.55% | 37.23% | 33.35% | 30.81% |
| Income Before Tax | 32.04% | 39.30% | 37.96% | 35.79% | 33.81% |
| Income Tax Expenses | -99.61% | -99.94% | -99.93% | 384.74% | 373.14% |
| Earnings from Continuing Operations | 61.60% | 60.07% | 55.85% | -45.08% | -45.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 61.60% | 60.07% | 55.85% | -45.08% | -45.01% |
| EBIT | 32.08% | 37.55% | 37.23% | 33.35% | 30.81% |
| EBITDA | 34.38% | 40.01% | 39.64% | 36.96% | 34.53% |
| EPS Basic | 61.75% | 60.22% | 55.98% | -44.51% | -44.26% |
| Normalized Basic EPS | 32.60% | 39.78% | 38.06% | 35.69% | 33.80% |
| EPS Diluted | 61.75% | 60.22% | 55.98% | -44.51% | -42.03% |
| Normalized Diluted EPS | 32.60% | 39.78% | 38.06% | 35.69% | 33.80% |
| Average Basic Shares Outstanding | 0.56% | 0.47% | 0.44% | 0.52% | 0.73% |
| Average Diluted Shares Outstanding | 0.56% | 0.47% | 0.44% | 0.52% | 0.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |